Viva Biotech Holdings Financial Overview
Viva Biotech Holdings's market cap is currently HK$4.00B. The company's EPS TTM is HK$0.0545991605; its P/E ratio is 21.65; Viva Biotech Holdings is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
